{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:53:07Z","timestamp":1790992387848,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011073","name":"VetAgro Sup","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011073","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-06160-0","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:44:56Z","timestamp":1786707896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting capillary leak in experimental sepsis and endotoxemia: a systematic review of therapeutic agents, methods and models in animal studies"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4855-9191","authenticated-orcid":false,"given":"Hugo","family":"Dumargne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Son","family":"Hong Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Louzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Allaouchiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdessalem","family":"Hammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auguste","family":"Dargent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"8","key":"6160_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"10219","key":"6160_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. The Lancet. 2020;395(10219):200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"The Lancet"},{"issue":"9","key":"6160_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, Van Der Poll T. severe sepsis and septic shock. N Engl J Med. 2013;369(9):840\u201351. https:\/\/doi.org\/10.1056\/NEJMra1208623.","journal-title":"N Engl J Med"},{"issue":"1","key":"6160_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13054-024-04875-6","volume":"28","author":"RR McMullan","year":"2024","unstructured":"McMullan RR, McAuley DF, O\u2019Kane CM, Silversides JA. Vascular leak in sepsis: physiological basis and potential therapeutic advances. Crit Care. 2024;28(1):97. https:\/\/doi.org\/10.1186\/s13054-024-04875-6.","journal-title":"Crit Care"},{"issue":"1","key":"6160_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40560-023-00694-z","volume":"11","author":"A Dargent","year":"2023","unstructured":"Dargent A, Dumargne H, Labruy\u00e8re M, Brezillon S, Brassart-Pasco S, Blot M, et al. Role of the interstitium during septic shock: a key to the understanding of fluid dynamics? J Intensive Care. 2023;11(1):44. https:\/\/doi.org\/10.1186\/s40560-023-00694-z.","journal-title":"J Intensive Care"},{"key":"6160_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-026-08361-1","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzanic W, M\u00f8ller MH, Alshamsi F, Azevedo LCP, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2026. Intensive Care Med. 2026. https:\/\/doi.org\/10.1007\/s00134-026-08361-1.","journal-title":"Intensive Care Med"},{"key":"6160_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181feeb15","author":"JH Boyd","year":"2011","unstructured":"Boyd JH, Forbes J, Nakadaaki T, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011. https:\/\/doi.org\/10.1097\/CCM.0b013e3181feeb15.","journal-title":"Crit Care Med"},{"key":"6160_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcrc.2018.08.018","volume":"48","author":"BM Tigabu","year":"2018","unstructured":"Tigabu BM, Davari M, Kebriaeezadeh A, Mojtahedzadeh M. Fluid volume, fluid balance and patient outcome in severe sepsis and septic shock: a systematic review. J Crit Care. 2018;48:153\u20139. https:\/\/doi.org\/10.1016\/j.jcrc.2018.08.018.","journal-title":"J Crit Care"},{"issue":"12","key":"6160_CR9","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1097\/CCM.0000000000004617","volume":"48","author":"AS Messmer","year":"2020","unstructured":"Messmer AS, Zingg C, M\u00fcller M, Gerber JL, Schefold JC, Pfortmueller CA. Fluid overload and mortality in adult critical care patients\u2014a systematic review and meta-analysis of observational studies. Crit Care Med. 2020;48(12):1862\u201370. https:\/\/doi.org\/10.1097\/CCM.0000000000004617.","journal-title":"Crit Care Med"},{"issue":"4","key":"6160_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1113\/jphysiol.1896.sp000596","volume":"19","author":"EH Starling","year":"1896","unstructured":"Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19(4):312\u201326. https:\/\/doi.org\/10.1113\/jphysiol.1896.sp000596.","journal-title":"J Physiol"},{"issue":"1","key":"6160_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, De Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14(1):43. https:\/\/doi.org\/10.1186\/1471-2288-14-43.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"6160_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002273","volume":"13","author":"MR Macleod","year":"2015","unstructured":"Macleod MR, Lawson McLean A, Kyriakopoulou A, Serghiou S, De Wilde A, Sherratt N, et al. Risk of bias in reports of in vivo research: a focus for improvement. PLOS Biol. 2015;13(10):e1002273. https:\/\/doi.org\/10.1371\/journal.pbio.1002273.","journal-title":"PLOS Biol"},{"issue":"1","key":"6160_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/SHK.0000000000001242","volume":"51","author":"C Libert","year":"2019","unstructured":"Libert C, Ayala A, Bauer M, Cavaillon JM, Deutschman C, Frostell C, et al. Part II: minimum quality threshold in preclinical sepsis studies (MQTiPSS) for types of infections and organ dysfunction endpoints. Shock. 2019;51(1):23\u201332. https:\/\/doi.org\/10.1097\/SHK.0000000000001242.","journal-title":"Shock"},{"key":"6160_CR14","doi-asserted-by":"publisher","first-page":"50062","DOI":"10.3791\/50062","volume":"73","author":"M Radu","year":"2013","unstructured":"Radu M, Chernoff J. An in vivo assay to test blood vessel permeability. J Vis Exp. 2013;73:50062. https:\/\/doi.org\/10.3791\/50062.","journal-title":"J Vis Exp"},{"key":"6160_CR15","doi-asserted-by":"publisher","first-page":"57037","DOI":"10.3791\/57037","volume":"139","author":"MJ Wick","year":"2018","unstructured":"Wick MJ, Harral JW, Loomis ZL, Dempsey EC. An optimized Evans blue protocol to assess vascular leak in the mouse. J Vis Exp. 2018;139:57037. https:\/\/doi.org\/10.3791\/57037.","journal-title":"J Vis Exp"},{"issue":"2","key":"6160_CR16","doi-asserted-by":"publisher","first-page":"L231","DOI":"10.1152\/ajplung.00049.2003","volume":"286","author":"JC Parker","year":"2004","unstructured":"Parker JC, Townsley MI. Evaluation of lung injury in rats and mice. Am J Physiol-Lung Cell Mol Physiol. 2004;286(2):L231\u201346. https:\/\/doi.org\/10.1152\/ajplung.00049.2003.","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"issue":"1","key":"6160_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13613-015-0081-9","volume":"5","author":"M Jozwiak","year":"2015","unstructured":"Jozwiak M, Teboul JL, Monnet X. Extravascular lung water in critical care: recent advances and clinical applications. Ann Intensive Care. 2015;5(1):38. https:\/\/doi.org\/10.1186\/s13613-015-0081-9.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"6160_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/MCC.0000000000000503","volume":"24","author":"T Tagami","year":"2018","unstructured":"Tagami T, Ong MEH. Extravascular lung water measurements in acute respiratory distress syndrome: why, how, and when? Curr Opin Crit Care. 2018;24(3):209\u201315. https:\/\/doi.org\/10.1097\/MCC.0000000000000503.","journal-title":"Curr Opin Crit Care"},{"issue":"5","key":"6160_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, et al. An official American thoracic society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44(5):725\u201338. https:\/\/doi.org\/10.1165\/rcmb.2009-0210ST.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"6160_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1152\/jappl.1985.59.2.564","volume":"59","author":"IM Dauber","year":"1985","unstructured":"Dauber IM, Pluss WT, VanGrondelle A, Trow RS, Weil JV. Specificity and sensitivity of noninvasive measurement of pulmonary vascular protein leak. J Appl Physiol. 1985;59(2):564\u201374. https:\/\/doi.org\/10.1152\/jappl.1985.59.2.564.","journal-title":"J Appl Physiol"},{"issue":"2","key":"6160_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2967\/jnmt.106.035972","volume":"35","author":"TA Manzone","year":"2007","unstructured":"Manzone TA, Dam HQ, Soltis D, Sagar VV. Blood volume analysis: a new technique and new clinical interest reinvigorate a classic study. J Nucl Med Technol. 2007;35(2):55\u201363. https:\/\/doi.org\/10.2967\/jnmt.106.035972.","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"6160_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s43556-020-00020-1","volume":"1","author":"A Molotkov","year":"2020","unstructured":"Molotkov A, Bhatt N, Doubrovin M, Castrillon J, Massa C, Gerber A, et al. Multimodality molecular imaging of the alveolar-capillary barrier in lung disease using albumin based optical and PET tracers. Mol Biomed. 2020;1(1):17. https:\/\/doi.org\/10.1186\/s43556-020-00020-1.","journal-title":"Mol Biomed"},{"issue":"1","key":"6160_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13613-025-01474-8","volume":"15","author":"J Joffre","year":"2025","unstructured":"Joffre J, Radermacher P, Kallel H, Marangon I, Rutault A, Levy Y, et al. Vascular leakage during circulatory failure: physiopathology, impact and treatments. Ann Intensive Care. 2025;15(1):79. https:\/\/doi.org\/10.1186\/s13613-025-01474-8.","journal-title":"Ann Intensive Care"},{"key":"6160_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000242755.74063.ED","author":"G Marx","year":"2006","unstructured":"Marx G, Pedder S, Smith L, Swaraj S, Grime S, Stockdale H, et al. Attenuation of capillary leakage by hydroxyethyl starch (130\/0.42) in a porcine model of septic shock. Crit Care Med. 2006. https:\/\/doi.org\/10.1097\/01.CCM.0000242755.74063.ED","journal-title":"Crit Care Med"},{"issue":"4","key":"6160_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/00024382-200404000-00008","volume":"21","author":"G Marx","year":"2004","unstructured":"Marx G, Pedder S, Smith L, Swaraj S, Grime S, Stockdale H, et al. Resuscitation from septic shock with capillary leakage: hydroxyethyl starch (130 kd), but not ringer\u2019s solution maintains plasma volume and systemic oxygenation. Shock. 2004;21(4):336\u201341. https:\/\/doi.org\/10.1097\/00024382-200404000-00008.","journal-title":"Shock"},{"issue":"3","key":"6160_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/SHK.0b013e3181fc9178","volume":"35","author":"M Yu","year":"2011","unstructured":"Yu M, Pei K, Moran S, Edwards KD, Domingo S, Steinemann S, et al. A prospective randomized trial using blood volume analysis in addition to pulmonary artery catheter, compared with pulmonary artery catheter alone, to guide shock resuscitation in critically Ill surgical patients. Shock. 2011;35(3):220\u20138. https:\/\/doi.org\/10.1097\/SHK.0b013e3181fc9178.","journal-title":"Shock"},{"key":"6160_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03968-4","author":"J Chandra","year":"2022","unstructured":"Chandra J, Armengol De La Hoz MA, Lee G, Lee A, Thoral P, Elbers P, et al. A novel vascular leak index identifies sepsis patients with a higher risk for in-hospital death and fluid accumulation. Crit Care. 2022. https:\/\/doi.org\/10.1186\/s13054-022-03968-4.","journal-title":"Crit Care"},{"issue":"1","key":"6160_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.1365-2168.2001.01632.x","volume":"88","author":"SJ Parker","year":"2001","unstructured":"Parker SJ, Watkins PE. Experimental models of Gram-negative sepsis. J Br Surg. 2001;88(1):22\u201330. https:\/\/doi.org\/10.1046\/j.1365-2168.2001.01632.x","journal-title":"J Br Surg"},{"issue":"1","key":"6160_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4161\/viru.26083PubMedPMID:24022070;PubMedCentralPMCID:PMC3916368","volume":"5","author":"MP Fink","year":"2014","unstructured":"Fink MP. Animal models of sepsis. Virul. 2014;5(1):143\u201353. https:\/\/doi.org\/10.4161\/viru.26083PubMedPMID:24022070;PubMedCentralPMCID:PMC3916368.","journal-title":"Virul"},{"issue":"1","key":"6160_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13613-019-0543-6PubMedPMID:31183570;PubMedCentralPMCID:PMC6557957","volume":"9","author":"A Guillon","year":"2019","unstructured":"Guillon A, Preau S, Aboab J, Azabou E, Jung B, Silva S, et al. Preclinical septic shock research: why we need an animal ICU. Ann Intensive Care. 2019;9(1):66. https:\/\/doi.org\/10.1186\/s13613-019-0543-6PubMedPMID:31183570;PubMedCentralPMCID:PMC6557957.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"6160_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/SHK.0000000000001243","volume":"51","author":"B Zingarelli","year":"2019","unstructured":"Zingarelli B, Coopersmith CM, Drechsler S, Efron P, Marshall JC, Moldawer L, et al. Part I: minimum quality threshold in preclinical sepsis studies (MQTiPSS) for study design and humane modeling endpoints. Shock. 2019;51(1):10\u201322. https:\/\/doi.org\/10.1097\/SHK.0000000000001243.","journal-title":"Shock"},{"issue":"1","key":"6160_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00011-026-02204-x","volume":"75","author":"T Iba","year":"2026","unstructured":"Iba T, Maier CL, Ferrer R, Nagakari K, Levy JH. Endotheliopathy within the thromboinflammatory network of sepsis-induced coagulopathy. Inflamm Res. 2026;75(1):59. https:\/\/doi.org\/10.1007\/s00011-026-02204-x.","journal-title":"Inflamm Res"},{"key":"6160_CR33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204242","author":"A Perner","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, \u00c5neman A, et al. Hydroxyethyl Starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. N Engl J Med. 2012. https:\/\/doi.org\/10.1056\/NEJMoa1204242.","journal-title":"N Engl J Med"},{"key":"6160_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004388.pub6","author":"AJ Mart\u00ed-Carvajal","year":"2012","unstructured":"Mart\u00ed-Carvajal AJ, Sol\u00e0 I, Gluud C, Lathyris D, Cardona AF. Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients. Cochrane Database Syst Rev. 2012. https:\/\/doi.org\/10.1002\/14651858.CD004388.pub6.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"6160_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00134-002-1260-3","volume":"28","author":"G Marx","year":"2002","unstructured":"Marx G, Cobas Meyer M, Schuerholz T, Vangerow B, Gratz KF, Hecker H, et al. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med. 2002;28(5):629\u201335. https:\/\/doi.org\/10.1007\/s00134-002-1260-3.","journal-title":"Intensive Care Med"},{"issue":"1","key":"6160_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12871-025-03518-9","volume":"26","author":"F Fonda","year":"2025","unstructured":"Fonda F, Orso D, Comisso I, De Crignis E, Meroi F, Galioto B, et al. Fluid balance and mortality in adult ICU patients with sepsis or septic shock: a systematic review and meta-analysis of observational studies. BMC Anesthesiol. 2025;26(1):16. https:\/\/doi.org\/10.1186\/s12871-025-03518-9.","journal-title":"BMC Anesthesiol"},{"key":"6160_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001102","author":"C Geven","year":"2018","unstructured":"Geven C, Peters E, Schroedter M, Struck J, Bergmann A, McCook O, et al. Effects of the humanized anti-adrenomedullin antibody adrecizumab (HAM8101) on vascular barrier function and survival in rodent models of systemic inflammation and sepsis. Shock. 2018. https:\/\/doi.org\/10.1097\/SHK.0000000000001102.","journal-title":"Shock"},{"issue":"11","key":"6160_CR38","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","volume":"47","author":"PF Laterre","year":"2021","unstructured":"Laterre PF, Pickkers P, Marx G, Wittebole X, Meziani F, Dugernier T, et al. Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial. Intensive Care Med. 2021;47(11):1284\u201394. https:\/\/doi.org\/10.1007\/s00134-021-06537-5.","journal-title":"Intensive Care Med"},{"key":"6160_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2020.100593","author":"F Luo","year":"2020","unstructured":"Luo F, Jiang W, Xu Y, Liu XM, Wang W, Zhang W, et al. The mechanisms involved in mesenchymal stem cell alleviation of sepsis-induced acute lung injury in mice: a pilot study. Curr Ther Res Clin Exp. 2020. https:\/\/doi.org\/10.1016\/j.curtheres.2020.100593.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"6","key":"6160_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jcyt.2023.02.002","volume":"25","author":"R Niu","year":"2023","unstructured":"Niu R, Pan P, Li C, Luo B, Ma H, Hao H, et al. Bone mesenchymal stromal cell-derived small extracellular vesicles inhibit inflammation and ameliorate sepsis via delivery of microRNA-21a-5p. Cytotherapy. 2023;25(6):625\u201339. https:\/\/doi.org\/10.1016\/j.jcyt.2023.02.002.","journal-title":"Cytotherapy"},{"key":"6160_CR41","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201705-1006OC","author":"LA McIntyre","year":"2018","unstructured":"McIntyre LA, Stewart DJ, Mei SHJ, Courtman D, Watpool I, Granton J, et al. Cellular immunotherapy for septic shock a phase I clinical trial. Am J Respir Crit Care Med. 2018. https:\/\/doi.org\/10.1164\/rccm.201705-1006OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"6160_CR42","doi-asserted-by":"publisher","unstructured":"Alp E, Gonen ZB, Gundogan K, Esmaoglu A, Kaynar L, Cetin A, et al. 2022 The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy. Cirocchi R, editor. Emerg Med Int. 2022:1\u20139. https:\/\/doi.org\/10.1155\/2022\/9222379","DOI":"10.1155\/2022\/9222379"},{"issue":"23","key":"6160_CR43","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1161\/CIRCULATIONAHA.112.134304","volume":"126","author":"J Aman","year":"2012","unstructured":"Aman J, van Bezu J, Damanafshan A, Huveneers S, Eringa EC, Vogel SM, et al. Effective treatment of edema and endothelial barrier dysfunction with imatinib. Circul. 2012;126(23):2728\u201338. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.134304.","journal-title":"Circul"},{"issue":"1","key":"6160_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10753-017-0659-5","volume":"41","author":"OS Zaki","year":"2018","unstructured":"Zaki OS, Safar MM, Ain-Shoka AA, Rashed LA. A Novel Role of a Chemotherapeutic Agent in a Rat Model of Endotoxemia: Modulation of the STAT-3 Signaling Pathway. Inflammation. 2018;41(1):20\u201332. https:\/\/doi.org\/10.1007\/s10753-017-0659-5.","journal-title":"Inflammation"},{"issue":"9","key":"6160_CR45","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S2213-2600(21)00237-X","volume":"9","author":"J Aman","year":"2021","unstructured":"Aman J, Duijvelaar E, Botros L, Kianzad A, Schippers JR, Smeele PJ, et al. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial. Lancet Respir Med. 2021;9(9):957\u201368. https:\/\/doi.org\/10.1016\/S2213-2600(21)00237-X.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"6160_CR46","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13054-023-04516-4","volume":"27","author":"LN Atmowihardjo","year":"2023","unstructured":"Atmowihardjo LN, Schippers JR, Duijvelaar E, Bartelink IH, Bet PM, Swart NEL, et al. Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial. Crit Care. 2023;27(1):226. https:\/\/doi.org\/10.1186\/s13054-023-04516-4.","journal-title":"Crit Care"},{"issue":"6","key":"6160_CR47","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1097\/CCM.0b013e3182120cb8","volume":"39","author":"BJ Fisher","year":"2011","unstructured":"Fisher BJ, Seropian IM, Kraskauskas D, Thakkar JN, Voelkel NF, Fowler AA 3rd, et al. Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury. Crit Care Med. 2011;39(6):1454\u201360. https:\/\/doi.org\/10.1097\/CCM.0b013e3182120cb8.","journal-title":"Crit Care Med"},{"issue":"4","key":"6160_CR48","doi-asserted-by":"publisher","first-page":"R409","DOI":"10.1152\/ajpregu.00153.2011PubMedPMID:22116513;PubMedCentralPMCID:PMC3293508","volume":"302","author":"G Zhou","year":"2012","unstructured":"Zhou G, Kamenos G, Pendem S, Wilson JX, Wu F. Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis. Am J Physiol Regul Integr Comp Physiol. 2012;302(4):R409-416. https:\/\/doi.org\/10.1152\/ajpregu.00153.2011PubMedPMID:22116513;PubMedCentralPMCID:PMC3293508.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"13","key":"6160_CR49","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.11825","volume":"322","author":"AA Fowler","year":"2019","unstructured":"Fowler AA, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, et al. Effect of Vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322(13):1261. https:\/\/doi.org\/10.1001\/jama.2019.11825.","journal-title":"JAMA"},{"issue":"25","key":"6160_CR50","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","volume":"386","author":"F Lamontagne","year":"2022","unstructured":"Lamontagne F, Masse MH, Menard J, Sprague S, Pinto R, Heyland DK, et al. Intravenous Vitamin C in adults with sepsis in the intensive care unit. N Engl J Med. 2022;386(25):2387\u201398. https:\/\/doi.org\/10.1056\/NEJMoa2200644.","journal-title":"N Engl J Med"},{"issue":"3","key":"6160_CR51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00011-015-0907-9","volume":"65","author":"J Chen","year":"2016","unstructured":"Chen J, Wang J, Su C, Qian W, Sun L, Sun H, et al. Urinary trypsin inhibitor attenuates LPS-induced endothelial barrier dysfunction by upregulation of vascular endothelial-cadherin expression. Inflamm Res. 2016;65(3):213\u201324. https:\/\/doi.org\/10.1007\/s00011-015-0907-9.","journal-title":"Inflamm Res"},{"key":"6160_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00823","author":"M Fang","year":"2018","unstructured":"Fang M, Zhong WH, Song WL, Deng YY, Yang DM, Xiong B, et al. Ulinastatin ameliorates pulmonary capillary endothelial permeability induced by sepsis through protection of tight junctions via inhibition of TNF-\u03b1 and related pathways. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.00823.","journal-title":"Front Pharmacol"},{"key":"6160_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108908","author":"Z Jin","year":"2022","unstructured":"Jin Z, Li MY, Tang L, Zou Y, Chen K. Protective effect of Ulinastatin on acute lung injury in diabetic sepsis rats. Int Immunopharmacol. 2022. https:\/\/doi.org\/10.1016\/j.intimp.2022.108908.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"6160_CR54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000521648","volume":"47","author":"T Li","year":"2022","unstructured":"Li T, Ji X, Liu J, Guo X, Pang R, Zhuang H, et al. Ulinastatin improves renal microcirculation by protecting endothelial cells and inhibiting autophagy in a septic rat model. Kidney Blood Press Res. 2022;47(4):256\u201369. https:\/\/doi.org\/10.1159\/000521648.","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"6160_CR55","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s00134-014-3278-8","volume":"40","author":"DR Karnad","year":"2014","unstructured":"Karnad DR, Bhadade R, Verma PK, Moulick ND, Daga MK, Chafekar ND, et al. Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study. Intensive Care Med. 2014;40(6):830\u20138. https:\/\/doi.org\/10.1007\/s00134-014-3278-8.","journal-title":"Intensive Care Med"},{"issue":"4","key":"6160_CR56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40268-025-00524-7PubMedPMID:41191281;PubMedCentralPMCID:PMC12756202","volume":"25","author":"A Yang","year":"2025","unstructured":"Yang A, Liu R, Lv K, Chen W, Han M, Yang Z. Efficacy and safety of Ulinastatin in post-traumatic sepsis: a randomized controlled trial. Drugs RD. 2025;25(4):333\u201341. https:\/\/doi.org\/10.1007\/s40268-025-00524-7PubMedPMID:41191281;PubMedCentralPMCID:PMC12756202.","journal-title":"Drugs RD"},{"issue":"3","key":"6160_CR57","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc12742PubMedPMID:23710641;PubMedCentralPMCID:PMC4056034","volume":"17","author":"SJ Jeong","year":"2013","unstructured":"Jeong SJ, Han SH, Kim CO, Choi JY, Kim JM. Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis. Crit Care Lond Engl. 2013;17(3):R97. https:\/\/doi.org\/10.1186\/cc12742PubMedPMID:23710641;PubMedCentralPMCID:PMC4056034.","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"6160_CR58","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000503787","volume":"57","author":"J Hauschildt","year":"2020","unstructured":"Hauschildt J, Schrimpf C, Thamm K, Retzlaff J, Idowu TO, von Kaisenberg C, et al. Dual pharmacological inhibition of angiopoietin-2 and VEGF-A in murine experimental sepsis. J Vasc Res. 2020;57(1):34\u201345. https:\/\/doi.org\/10.1159\/000503787.","journal-title":"J Vasc Res"},{"issue":"1","key":"6160_CR59","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41467-021-21085-8PubMedPMID:33547300;PubMedCentralPMCID:PMC7864918","volume":"12","author":"J Pang","year":"2021","unstructured":"Pang J, Xu F, Aondio G, Li Y, Fumagalli A, Lu M, et al. Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nat Commun. 2021;12(1):814. https:\/\/doi.org\/10.1038\/s41467-021-21085-8PubMedPMID:33547300;PubMedCentralPMCID:PMC7864918.","journal-title":"Nat Commun"},{"issue":"2","key":"6160_CR60","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/00003246-200102000-00028","volume":"29","author":"OV Evgenov","year":"2001","unstructured":"Evgenov OV, Sager G, Bjertnaes LJ. Methylene blue reduces lung fluid filtration during the early phase of endotoxemia in awake sheep. Crit Care Med. 2001;29(2):374\u20139. https:\/\/doi.org\/10.1097\/00003246-200102000-00028.","journal-title":"Crit Care Med"},{"issue":"1","key":"6160_CR61","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13054-023-04397-7PubMedPMID:36915146;PubMedCentralPMCID:PMC10010212","volume":"27","author":"M Ibarra-Estrada","year":"2023","unstructured":"Ibarra-Estrada M, Kattan E, Aguilera-Gonz\u00e1lez P, Sandoval-Plascencia L, Rico-Jauregui U, G\u00f3mez-Partida CA, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023;27(1):110. https:\/\/doi.org\/10.1186\/s13054-023-04397-7PubMedPMID:36915146;PubMedCentralPMCID:PMC10010212.","journal-title":"Crit Care"},{"key":"6160_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000300","author":"H Yasuda","year":"2006","unstructured":"Yasuda H, Yuen PS, Hu X, Zhou H, Star RA. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int. 2006. https:\/\/doi.org\/10.1038\/sj.ki.5000300.","journal-title":"Kidney Int"},{"issue":"2","key":"6160_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/bja\/aep361","volume":"104","author":"CC McGown","year":"2010","unstructured":"McGown CC, Brown NJ, Hellewell PG, Reilly CS, Brookes ZLS. Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III. Br J Anaesth. 2010;104(2):183\u201390. https:\/\/doi.org\/10.1093\/bja\/aep361.","journal-title":"Br J Anaesth"},{"key":"6160_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038917","author":"J Grommes","year":"2012","unstructured":"Grommes J, Vijayan S, Drechsler M, Hartwig H, M\u00f6rgelin M, Dembinski R, et al. Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation. PLoS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0038917.","journal-title":"PLoS ONE"},{"issue":"5","key":"6160_CR65","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00210-015-1100-y","volume":"388","author":"CC McGown","year":"2015","unstructured":"McGown CC, Brookes ZLS, Hellewell PG, Ross JJ, Brown NJ. Atorvastatin reduces endotoxin-induced microvascular inflammation via NOSII. Naunyn Schmiedebergs Arch Pharmacol. 2015;388(5):557\u201364. https:\/\/doi.org\/10.1007\/s00210-015-1100-y.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"765","key":"6160_CR66","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ejphar.2015.09.009","volume":"15","author":"S Choudhury","year":"2015","unstructured":"Choudhury S, Kandasamy K, Maruti BS, Addison MP, Kasa JK, Darzi SA, et al. Atorvastatin along with imipenem attenuates acute lung injury in sepsis through decrease in inflammatory mediators and bacterial load. Eur J Pharmacol. 2015;15(765):447\u201356. https:\/\/doi.org\/10.1016\/j.ejphar.2015.09.009.","journal-title":"Eur J Pharmacol"},{"key":"6160_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108077","volume":"100","author":"Y Ren","year":"2021","unstructured":"Ren Y, Li L, Wang MM, Cao LP, Sun ZR, Yang ZZ, et al. Pravastatin attenuates sepsis-induced acute lung injury through decreasing pulmonary microvascular permeability via inhibition of Cav-1\/eNOS pathway. Int Immunopharmacol. 2021;100:108077. https:\/\/doi.org\/10.1016\/j.intimp.2021.108077.","journal-title":"Int Immunopharmacol"},{"issue":"18","key":"6160_CR68","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","volume":"371","author":"DF McAuley","year":"2014","unstructured":"McAuley DF, Laffey JG, O\u2019Kane CM, Perkins GD, Mullan B, Trinder TJ, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med. 2014;371(18):1695\u2013703. https:\/\/doi.org\/10.1056\/NEJMoa1403285.","journal-title":"N Engl J Med"},{"key":"6160_CR69","doi-asserted-by":"publisher","unstructured":"The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome. N Engl J Med. 2014;370 23 :2191\u2013200. https:\/\/doi.org\/10.1056\/NEJMoa1401520.","DOI":"10.1056\/NEJMoa1401520"},{"issue":"6","key":"6160_CR70","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1213\/00000539-198912000-00004","volume":"69","author":"CW Armistead","year":"1989","unstructured":"Armistead CW, Vincent JL, Preiser JC, De Backer D. Thuc Le Minh null Hypertonic saline solution-hetastarch for fluid resuscitation in experimental septic shock. Anesth Analg. 1989;69(6):714\u201320.","journal-title":"Anesth Analg"},{"issue":"1","key":"6160_CR71","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00024382-199907000-00011","volume":"12","author":"H de Carvalho","year":"1999","unstructured":"de Carvalho H, Matos JA, Bouskela E, Svensj\u00f6 E. Vascular permeability increase and plasma volume loss induced by endotoxin was attenuated by hypertonic saline with or without dextran. Shock Augusta Ga. 1999;12(1):75\u201380. https:\/\/doi.org\/10.1097\/00024382-199907000-00011.","journal-title":"Shock Augusta Ga"},{"issue":"3","key":"6160_CR72","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2213-2600(17)30046-2","volume":"5","author":"P Asfar","year":"2017","unstructured":"Asfar P, Schortgen F, Boisram\u00e9-Helms J, Charpentier J, Gu\u00e9rot E, Megarbane B, et al. Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial. Lancet Respir Med. 2017;5(3):180\u201390. https:\/\/doi.org\/10.1016\/S2213-2600(17)30046-2.","journal-title":"Lancet Respir Med"},{"key":"6160_CR73","doi-asserted-by":"publisher","DOI":"10.1042\/CS20040001","author":"RA Assaly","year":"2004","unstructured":"Assaly RA, Azizi M, Kennedy DJ, Amauro C, Zaher A, Houts FW, et al. Plasma expansion by polyethylene-glycol-modified albumin. Clin Sci Lond Engl 1979. 2004. https:\/\/doi.org\/10.1042\/CS20040001.","journal-title":"Clin Sci Lond Engl 1979"},{"issue":"15","key":"6160_CR74","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1305727.","journal-title":"N Engl J Med"},{"issue":"2","key":"6160_CR75","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.59297","volume":"9","author":"Y Sakr","year":"2026","unstructured":"Sakr Y, Nierhaus A, Schumacher U, Utzolino S, Jaschinski U, Petros S, et al. Albumin replacement therapy in septic shock: a randomized clinical trial. JAMA Netw Open. 2026;9(2):e2559297. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.59297.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"6160_CR76","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1097\/CCM.0000000000006348","volume":"52","author":"AJ Gray","year":"2024","unstructured":"Gray AJ, Oatey K, Grahamslaw J, Irvine S, Cafferkey J, Kennel T, et al. Albumin versus balanced crystalloid for the early resuscitation of sepsis: an open parallel-group randomized feasibility trial\u2014 the ABC-sepsis trial. Crit Care Med. 2024;52(10):1520\u201332. https:\/\/doi.org\/10.1097\/CCM.0000000000006348.","journal-title":"Crit Care Med"},{"issue":"7","key":"6160_CR77","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1097\/CCM.0000000000000300PubMedPMID:24674922;PubMedCentralPMCID:PMC4346299","volume":"42","author":"MO Maybauer","year":"2014","unstructured":"Maybauer MO, Maybauer DM, Enkhbaatar P, Laporte R, Wi\u015bniewska H, Traber LD, et al. The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis. Crit Care Med. 2014;42(7):e525\u201333. https:\/\/doi.org\/10.1097\/CCM.0000000000000300PubMedPMID:24674922;PubMedCentralPMCID:PMC4346299.","journal-title":"Crit Care Med"},{"issue":"1","key":"6160_CR78","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCM.0000000000001380PubMedPMID:26496451;PubMedCentralPMCID:PMC4684247","volume":"44","author":"X He","year":"2016","unstructured":"He X, Su F, Taccone FS, Laporte R, Kj\u00f8lbye AL, Zhang J, et al. A selective V(1A) receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock. Crit Care Med. 2016;44(1):23\u201331. https:\/\/doi.org\/10.1097\/CCM.0000000000001380PubMedPMID:26496451;PubMedCentralPMCID:PMC4684247.","journal-title":"Crit Care Med"},{"issue":"15","key":"6160_CR79","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1001\/jama.2019.14607","volume":"322","author":"PF Laterre","year":"2019","unstructured":"Laterre PF, Berry SM, Blemings A, Carlsen JE, Fran\u00e7ois B, Graves T, et al. Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial. JAMA. 2019;322(15):1476. https:\/\/doi.org\/10.1001\/jama.2019.14607.","journal-title":"JAMA"},{"issue":"1","key":"6160_CR80","doi-asserted-by":"publisher","first-page":"H209","DOI":"10.1152\/ajpheart.00946.2003","volume":"287","author":"B Levy","year":"2004","unstructured":"Levy B, Vall\u00e9e C, Lauzier F, Plante GE, Mansart A, Mallie JP, et al. Comparative effects of vasopressin, norepinephrine, and L-canavanine, a selective inhibitor of inducible nitric oxide synthase, in endotoxic shock. Am J Physiol Heart Circ Physiol. 2004;287(1):H209-215. https:\/\/doi.org\/10.1152\/ajpheart.00946.2003.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6160_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-009-1470-z","author":"S Rehberg","year":"2009","unstructured":"Rehberg S, Ertmer C, K\u00f6hler G, Spiegel HU, Morelli A, Lange M, et al. Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock. Intensive Care Med. 2009. https:\/\/doi.org\/10.1007\/s00134-009-1470-z.","journal-title":"Intensive Care Med"},{"key":"6160_CR82","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181ef4694","author":"S Rehberg","year":"2010","unstructured":"Rehberg S, Ertmer C, Vincent JL, Spiegel HU, K\u00f6hler G, Erren M, et al. Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med. 2010. https:\/\/doi.org\/10.1097\/CCM.0b013e3181ef4694.","journal-title":"Crit Care Med"},{"issue":"5","key":"6160_CR83","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509. https:\/\/doi.org\/10.1001\/jama.2016.10485.","journal-title":"JAMA"},{"issue":"17","key":"6160_CR84","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","volume":"375","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RML, Santhakumaran S, et al. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med. 2016;375(17):1638\u201348. https:\/\/doi.org\/10.1056\/NEJMoa1609409.","journal-title":"N Engl J Med"},{"issue":"8","key":"6160_CR85","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/CCM.0000000000005885","volume":"51","author":"GA Ospina-Tasc\u00f3n","year":"2023","unstructured":"Ospina-Tasc\u00f3n GA, Aldana JL, Garc\u00eda Mar\u00edn AF, Calder\u00f3n-Tapia LE, Marulanda A, Escobar EP, et al. Immediate norepinephrine in endotoxic shock: effects on regional and microcirculatory flow. Crit Care Med. 2023;51(8):e157\u201368. https:\/\/doi.org\/10.1097\/CCM.0000000000005885.","journal-title":"Crit Care Med"},{"key":"6160_CR86","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201806-1034OC","author":"C Permpikul","year":"2019","unstructured":"Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER) a randomized trial. Am J Respir Crit Care Med. 2019. https:\/\/doi.org\/10.1164\/rccm.201806-1034OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"6160_CR87","doi-asserted-by":"publisher","DOI":"10.36468\/pharmaceutical-sciences.761","author":"H Xiao","year":"2021","unstructured":"Xiao H, Li S, Yang J, Yao H, Zheng J. Effects of dexmedetomidine on inflammatory factors and mitogen activated protein kinase-related signaling pathways of alveolar lavage fluid in mice with lipopolysaccharide-induced acute lung injury. Indian J Pharm Sci. 2021. https:\/\/doi.org\/10.36468\/pharmaceutical-sciences.761.","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"6160_CR88","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40635-023-00542-2","volume":"11","author":"M Elayashy","year":"2023","unstructured":"Elayashy M, Elsayed EA, Mukhtar AM, Kasem S, Elmetwally SA, Habib S, et al. Role of dexmedetomidine in modifying immune paralysis in patients with septic shock: randomized controlled trial. Intensive Care Med Exp. 2023;11(1):59. https:\/\/doi.org\/10.1186\/s40635-023-00542-2.","journal-title":"Intensive Care Med Exp"},{"issue":"4","key":"6160_CR89","doi-asserted-by":"publisher","first-page":"e884","DOI":"10.1097\/CCM.0000000000006608","volume":"53","author":"A Dargent","year":"2025","unstructured":"Dargent A, Bourredjem A, Jacquier M, Bohe J, Argaud L, Levy B, et al. Dexmedetomidine to reduce vasopressor resistance in refractory septic shock: \u03b12 agonist dexmedetomidine for REfractory septic shock (ADRESS): a double-blind randomized controlled pilot trial. Crit Care Med. 2025;53(4):e884\u201396. https:\/\/doi.org\/10.1097\/CCM.0000000000006608.","journal-title":"Crit Care Med"},{"issue":"13","key":"6160_CR90","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1001\/jama.2017.2088","volume":"317","author":"Y Kawazoe","year":"2017","unstructured":"Kawazoe Y, Miyamoto K, Morimoto T, Yamamoto T, Fuke A, Hashimoto A, et al. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: a randomized clinical trial. JAMA. 2017;317(13):1321. https:\/\/doi.org\/10.1001\/jama.2017.2088.","journal-title":"JAMA"},{"issue":"6","key":"6160_CR91","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.chest.2024.06.3794","volume":"166","author":"AR Ezz Al-regal","year":"2024","unstructured":"Ezz Al-regal AR, Ramzy EA, Atia AAA, Emara MM. Dexmedetomidine for reducing mortality in patients with septic shock. Chest. 2024;166(6):1394\u2013405. https:\/\/doi.org\/10.1016\/j.chest.2024.06.3794.","journal-title":"Chest"},{"issue":"3 Pt 1","key":"6160_CR92","doi-asserted-by":"publisher","first-page":"L470","DOI":"10.1152\/ajplung.1996.271.3.L470","volume":"271","author":"M Uchiba","year":"1996","unstructured":"Uchiba M, Okajima K, Murakami K, Johno M, Okabe H, Takatsuki K. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation. Am J Physiol. 1996;271(3 Pt 1):L470-475. https:\/\/doi.org\/10.1152\/ajplung.1996.271.3.L470.","journal-title":"Am J Physiol"},{"key":"6160_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(199702)54:2118:aid-ajh43.0.co;2-23","author":"M Uchiba","year":"1997","unstructured":"Uchiba M, Okajima K, Murakami K, Johno M, Okabe H, Takatsuki K. Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats. Am J Hematol. 1997. https:\/\/doi.org\/10.1002\/(sici)1096-8652(199702)54:2118:aid-ajh43.0.co;2-23.","journal-title":"Am J Hematol"},{"key":"6160_CR94","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2200094","author":"H Kono","year":"2023","unstructured":"Kono H, Hosomura N, Amemiya H, Kawaida H, Furuya S, Shoda K, et al. Recombinant human thrombomodulin reduces mortality and acute lung injury caused by septic peritonitis in rats. ImmunoHorizons. 2023. https:\/\/doi.org\/10.4049\/immunohorizons.2200094.","journal-title":"ImmunoHorizons"},{"issue":"20","key":"6160_CR95","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA. 2019;321(20):1993. https:\/\/doi.org\/10.1001\/jama.2019.5358.","journal-title":"JAMA"},{"issue":"4","key":"6160_CR96","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1172\/jci110123PubMedPMID:7009652;PubMedCentralPMCID:PMC370670","volume":"67","author":"KL Brigham","year":"1981","unstructured":"Brigham KL, Bowers RE, McKeen CR. Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J Clin Invest. 1981;67(4):1103\u201310. https:\/\/doi.org\/10.1172\/jci110123PubMedPMID:7009652;PubMedCentralPMCID:PMC370670.","journal-title":"J Clin Invest"},{"key":"6160_CR97","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1984.01390210025007","author":"WW Tom","year":"1984","unstructured":"Tom WW, Dotterrer RM, Villalba M. Steroid effect on capillary permeability in gram-negative septic shock. Evaluation by vitreous fluorophotometry. Arch Surg Chic Ill 1960. 1984. https:\/\/doi.org\/10.1001\/archsurg.1984.01390210025007.","journal-title":"Arch Surg Chic Ill 1960"},{"issue":"9","key":"6160_CR98","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1705716.","journal-title":"N Engl J Med"},{"issue":"9","key":"6160_CR99","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa1705835.","journal-title":"N Engl J Med"},{"issue":"1","key":"6160_CR100","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1124\/jpet.116.239509PubMedPMID:28167639;PubMedCentralPMCID:PMC5363766","volume":"361","author":"JW Song","year":"2017","unstructured":"Song JW, Zullo JA, Liveris D, Dragovich M, Zhang XF, Goligorsky MS. Therapeutic restoration of endothelial glycocalyx in sepsis. J Pharmacol Exp Ther. 2017;361(1):115\u201321. https:\/\/doi.org\/10.1124\/jpet.116.239509PubMedPMID:28167639;PubMedCentralPMCID:PMC5363766.","journal-title":"J Pharmacol Exp Ther"},{"issue":"14","key":"6160_CR101","doi-asserted-by":"publisher","first-page":"1172892","DOI":"10.3389\/fimmu.2023.1172892","volume":"8","author":"J Ying","year":"2023","unstructured":"Ying J, Zhang C, Wang Y, Liu T, Yu Z, Wang K, et al. Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis. Front Immunol. 2023;8(14):1172892. https:\/\/doi.org\/10.3389\/fimmu.2023.1172892.","journal-title":"Front Immunol"},{"issue":"3","key":"6160_CR102","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1272\/jnms.81.130","volume":"81","author":"H Koami","year":"2014","unstructured":"Koami H, Sakamoto Y, Miyasho T, Itami T, Tamura J, Ishizuka T, et al. The effects of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment in endotoxemic pigs. J Nippon Med Sch Nippon Ika Daigaku Zasshi. 2014;81(3):130\u20138. https:\/\/doi.org\/10.1272\/jnms.81.130.","journal-title":"J Nippon Med Sch Nippon Ika Daigaku Zasshi"},{"issue":"14","key":"6160_CR103","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, et al. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA. 2018;320(14):1455. https:\/\/doi.org\/10.1001\/jama.2018.14618.","journal-title":"JAMA"},{"issue":"5","key":"6160_CR104","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S2213-2600(26)00047-0","volume":"14","author":"JA Neyra","year":"2026","unstructured":"Neyra JA, Legrand M, Tidswell MA, Al-Khafaji A, Galphin C, Rains R, et al. Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial. Lancet Respir Med. 2026;14(5):443\u201352. https:\/\/doi.org\/10.1016\/S2213-2600(26)00047-0.","journal-title":"Lancet Respir Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06160-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:04:26Z","timestamp":1790989466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06160-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6160"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06160-0","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"509"}}